135 related articles for article (PubMed ID: 28517239)
1. The dose-effect relationship of baclofen in alcohol dependence: A 1-year cohort study.
Pignon B; Labreuche J; Auffret M; Gautier S; Deheul S; Simioni N; Cottencin O; Bordet R; Duhamel A; Rolland B
Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28517239
[TBL] [Abstract][Full Text] [Related]
2. Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation.
Rolland B; Labreuche J; Duhamel A; Deheul S; Gautier S; Auffret M; Pignon B; Valin T; Bordet R; Cottencin O
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1631-6. PubMed ID: 26095229
[TBL] [Abstract][Full Text] [Related]
3. Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.
Chaignot C; Zureik M; Rey G; Dray-Spira R; Coste J; Weill A
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1239-1248. PubMed ID: 30251424
[TBL] [Abstract][Full Text] [Related]
4. High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial.
Müller CA; Geisel O; Pelz P; Higl V; Krüger J; Stickel A; Beck A; Wernecke KD; Hellweg R; Heinz A
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1167-77. PubMed ID: 26048580
[TBL] [Abstract][Full Text] [Related]
5. Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort study.
Rolland B; Valin T; Langlois C; Auffret M; Gautier S; Deheul S; Danel T; Bordet R; Cottencin O
Int Clin Psychopharmacol; 2015 Jan; 30(1):49-53. PubMed ID: 25356633
[TBL] [Abstract][Full Text] [Related]
6. High-dose baclofen for treatment-resistant alcohol dependence.
Pastor A; Jones DM; Currie J
J Clin Psychopharmacol; 2012 Apr; 32(2):266-8. PubMed ID: 22367662
[TBL] [Abstract][Full Text] [Related]
7. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
Addolorato G; Leggio L; Ferrulli A; Cardone S; Bedogni G; Caputo F; Gasbarrini G; Landolfi R;
Alcohol Alcohol; 2011; 46(3):312-7. PubMed ID: 21414953
[TBL] [Abstract][Full Text] [Related]
8. One year of baclofen in 100 patients with or without cirrhosis: a French real-life experience.
Barrault C; Lison H; Roudot-Thoraval F; Garioud A; Costentin C; Béhar V; Medmoun M; Pulwermacher G; Hagège H; Cadranel JF
Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1155-1160. PubMed ID: 28727631
[TBL] [Abstract][Full Text] [Related]
9. A Randomized, Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients-The ALPADIR Study.
Reynaud M; Aubin HJ; Trinquet F; Zakine B; Dano C; Dematteis M; Trojak B; Paille F; Detilleux M
Alcohol Alcohol; 2017 Jul; 52(4):439-446. PubMed ID: 28525555
[TBL] [Abstract][Full Text] [Related]
10. Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol.
Rolland B; Auffret M; Labreuche J; Lapeyre-Mestre M; Dib M; Kemkem A; Grit I; Drelon M; Duhamel A; Cabe N; Vabret F; Guillin O; Baguet A; Masquelier C; Dervaux A; Deheul S; Bordet R; Carton L; Cottencin O; Jardri R; Gautier S
Expert Opin Drug Saf; 2017 Feb; 16(2):125-132. PubMed ID: 27984918
[TBL] [Abstract][Full Text] [Related]
11. A prospective cohort study examining the effectiveness of baclofen in the maintenance of abstinence in alcohol use disorder patients attending a joint liver and alcohol treatment clinic.
Owens L; Thompson A; Rose A; Gilmore I; Pirmohamed M; Richardson P
Alcohol; 2017 Aug; 62():11-15. PubMed ID: 28755747
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial.
Beraha EM; Salemink E; Goudriaan AE; Bakker A; de Jong D; Smits N; Zwart JW; Geest DV; Bodewits P; Schiphof T; Defourny H; van Tricht M; van den Brink W; Wiers RW
Eur Neuropsychopharmacol; 2016 Dec; 26(12):1950-1959. PubMed ID: 27842939
[TBL] [Abstract][Full Text] [Related]
13. Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.
Prescrire Int; 2013 Sep; 22(141):214-7. PubMed ID: 24171218
[TBL] [Abstract][Full Text] [Related]
14. Randomized open-label trial of baclofen for relapse prevention in alcohol dependence.
Gupta M; Verma P; Rastogi R; Arora S; Elwadhi D
Am J Drug Alcohol Abuse; 2017 May; 43(3):324-331. PubMed ID: 27808555
[TBL] [Abstract][Full Text] [Related]
15. Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessment.
Rolland B; Auffret M; Franchitto N
Expert Opin Drug Saf; 2016 Jun; 15(6):747-51. PubMed ID: 26987987
[TBL] [Abstract][Full Text] [Related]
16. [Double blind placebo controlled randomized pilot clinical trial of baclofen (Baclosan®) for alcohol dependence].
Krupitsky EM; Rybakova KV; Kiselev AS; Alexeeva YV; Berntsev VA; Chekhlaty EI; Zubova EY; Popov YV; Neznanov NG
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):53-62. PubMed ID: 26356398
[TBL] [Abstract][Full Text] [Related]
17. Abstinence and 'low-risk' consumption 1 year after the initiation of high-dose baclofen: a retrospective study among 'high-risk' drinkers.
Rigal L; Alexandre-Dubroeucq C; de Beaurepaire R; Le Jeunne C; Jaury P
Alcohol Alcohol; 2012; 47(4):439-42. PubMed ID: 22434664
[TBL] [Abstract][Full Text] [Related]
18. Alcohol addiction - the safety of available approved treatment options.
Antonelli M; Ferrulli A; Sestito L; Vassallo GA; Tarli C; Mosoni C; Rando MM; Mirijello A; Gasbarrini A; Addolorato G
Expert Opin Drug Saf; 2018 Feb; 17(2):169-177. PubMed ID: 29120249
[TBL] [Abstract][Full Text] [Related]
19. Clinical Predictors of Response to Baclofen in the Treatment of Alcohol use Disorder: Results from the BacALD Trial.
Rombouts SA; Baillie A; Haber PS; Morley KC
Alcohol Alcohol; 2019 May; 54(3):272-278. PubMed ID: 30977770
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of oral baclofen at steady-state in alcoholic-dependent adult patients.
Chevillard L; Sabo N; Tod M; Labat L; Chasport C; Chevaleyre C; Thibaut F; Barré J; Azuar J; Questel F; Vorspan F; Bloch V; Bellivier F; Granger B; Barrault C; Declèves X
Fundam Clin Pharmacol; 2018 Apr; 32(2):239-248. PubMed ID: 29091319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
